BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19942325)

  • 1. Novel phosphoramidates with porphine and nitrogenous drug: one-pot synthesis and orientation to cancer cells.
    Wang ZW; Guo CC; Xie WZ; Liu CZ; Xiao CG; Tan Z
    Eur J Med Chem; 2010 Mar; 45(3):890-5. PubMed ID: 19942325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of LNA phosphoramidates.
    Jensen J; Sjøgren G; Hansen JB; Rosenbohm C; Koch T
    Nucleosides Nucleotides Nucleic Acids; 2008 Jan; 27(1):37-42. PubMed ID: 18188768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel phosphoramidate derivatives of NSAID 3-hydroxypropylamides: synthesis, cytostatic and antiviral activity evaluations.
    Wittine K; Benci K; Rajić Z; Zorc B; Kralj M; Marjanović M; Pavelić K; De Clercq E; Andrei G; Snoeck R; Balzarini J; Mintas M
    Eur J Med Chem; 2009 Jan; 44(1):143-51. PubMed ID: 18485540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anticancer activity of some 5-fluoro-2'-deoxyuridine phosphoramidates.
    Lewandowska M; Ruszkowski P; Chojnacka K; Kleczewska N; Hoffmann M; Kacprzak K; Celewicz L
    Bioorg Med Chem; 2016 May; 24(10):2330-41. PubMed ID: 27073055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient strategy for the synthesis of 1-chloroethyl phosphates and phosphoramidates.
    Kumpulainen H; Järvinen T; Saari R; Lehtonen M; Vepsäläinen J
    J Org Chem; 2005 Oct; 70(22):9056-8. PubMed ID: 16238353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
    Wu W; Borch RF
    Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and antitumor activity of bile acid-polyamine-nucleoside conjugates.
    Wu D; Ji S; Wu Y; Ju Y; Zhao Y
    Bioorg Med Chem Lett; 2007 Jun; 17(11):2983-6. PubMed ID: 17416522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel nucleoside analogue phosphorothioamidate prodrugs and in vitro anticancer evaluation against RKO human colon carcinoma cells.
    Liu W; Zhang L; Zhou H; Yang C; Miao Z; Zhao Y
    Nucleosides Nucleotides Nucleic Acids; 2013; 32(4):161-73. PubMed ID: 24001190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro enzymatic and antiviral evaluation of phosphoramidate d4T derivatives as chain terminators.
    Yang S; Pannecouque C; Lescrinier E; Giraut A; Herdewijn P
    Org Biomol Chem; 2012 Jan; 10(1):146-53. PubMed ID: 22069085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacin.
    McGuigan C; Thiery JC; Daverio F; Jiang WG; Davies G; Mason M
    Bioorg Med Chem; 2005 May; 13(9):3219-27. PubMed ID: 15809157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs.
    Duan JX; Jiao H; Kaizerman J; Stanton T; Evans JW; Lan L; Lorente G; Banica M; Jung D; Wang J; Ma H; Li X; Yang Z; Hoffman RM; Ammons WS; Hart CP; Matteucci M
    J Med Chem; 2008 Apr; 51(8):2412-20. PubMed ID: 18257544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase inhibitors--oligonucleotide phosphoramidates as potential therapeutic agents.
    Gryaznov S; Pongracz K; Matray T; Schultz R; Pruzan R; Aimi J; Chin A; Harley C; Shea-Herbert B; Shay J; Oshima Y; Asai A; Yamashita Y
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):401-10. PubMed ID: 11563055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroalkyl piperazine and nitrogen mustard porphyrins: synthesis and anticancer activity.
    Guo CC; Tong RB; Li KL
    Bioorg Med Chem; 2004 May; 12(9):2469-75. PubMed ID: 15080942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alkyl groups on the cellular hydrolysis of stavudine phosphoramidates.
    Venkatachalam TK; Sarquis M; Qazi S; Uckun FM
    Bioorg Med Chem; 2006 Sep; 14(18):6420-33. PubMed ID: 16782353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of naphthalene-2-carboxamides as reversal agents in MDR cancer.
    Lokhande TN; Viswanathan CL; Joshi A; Juvekar A
    Bioorg Med Chem; 2006 Sep; 14(17):6022-6. PubMed ID: 16730993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
    McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer.
    Gududuru V; Hurh E; Dalton JT; Miller DD
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of carbohydrate methyl phosphoramidates.
    Ashmus RA; Lowary TL
    Org Lett; 2014 May; 16(9):2518-21. PubMed ID: 24783964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryloxy Triester Phosphoramidates as Phosphoserine Prodrugs: A Proof of Concept Study.
    Miccoli A; Dhiani BA; Thornton PJ; Lambourne OA; James E; Kadri H; Mehellou Y
    ChemMedChem; 2020 Apr; 15(8):671-674. PubMed ID: 32162793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.